The Vienna and New York NGO Committees on Drugs release a report outlining the issues, challenges, and opportunities experienced by civil society working in the field of drugs.
Holland et. al. advocate for urgent implementation and rapid evidence generation for safer drug supply initiatives, especially in areas where drug deaths are escalating due to an unregulated drug supply.
Rammohan et. al. report decreased overdose mortality rates in areas with a supervised consumption services, underscoring the need and value of these interventions.
C-EHRN argues for coordinated, context-dependent, and well-funded responses, including harm reduction strategies, to achieve the 2030 elimination goal.
Fleming et al. call for scaling up housing-based interventions, and better understanding the role that contextual factors play in overdose vulnerability.
The Eurasian Harm Reduction Association (EHRA) collated insights and recommendations from a regional project that aims to empower communities through community-led monitoring mechanisms.
Jegede et. al. discuss how systemic racism contribute to health inequities experienced by minoritised communities and proposes how harm reduction can be a tool towards equity.
IDPC, Viso Mutop and GDPO explore the report's discussion of buoyant drug markets and UNODC's stance on key issues like decriminalisation, human rights and environmental impact, noting the growing influence of green criminology and its potential to reshape perspectives.
